博文
USP1-ATF4-CD98hc ENKTL淋巴瘤
||
USP1-ATF4-CD98hc调控ENKTL淋巴瘤患者耐药的新机制
https://www.ebiotrade.com/newsf/2024-11/20241103064603650.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=bd52da9c-924e-4673-b7ab-6314d97c44fd
http://www.pubmedplus.cn/P/SearchQuickResult?wd=64ef1e89-6ba1-4c4d-bfd7-fd656295a39c
| 01. | Humans | 349 篇 | 100.000% |
| 02. | Neoplasm, Residual | 349 篇 | 100.000% |
| 03. | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 349 篇 | 100.000% |
| 04. | Child | 186 篇 | 53.295% |
| 05. | Male | 151 篇 | 43.266% |
| 06. | Female | 147 篇 | 42.120% |
| 07. | Adolescent | 127 篇 | 36.390% |
| 08. | Prognosis | 124 篇 | 35.530% |
| 09. | Child, Preschool | 112 篇 | 32.092% |
| 10. | Adult | 103 篇 | 29.513% |
https://blog.sciencenet.cn/blog-280034-1458276.html
上一篇：化学重编程与再生医学
下一篇：人工智能带来的电子废弃物
扫一扫，分享此博文